Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Impact of moderate to vigorous physical activity on systemic vascular resistance in Danish adults with recently diagnosed type 2 diabetes: a cross-sectional study

Abstract

Strenuous physical activity alleviates the risk of elevated blood pressure (BP) presumably through a reduction in systemic vascular resistance (SVR). Using logistic multivariate regression models, we investigated whether moderate to vigorous physical activity (MVPA) was negatively associated with high SVR among adults with Type 2 Diabetes (T2DM). Additionally, we assessed associations between other cardiometabolic risk factors and SVR. SVR was assessed using thoracic electrical bioimpedance; high SVR was defined as ≥20% above normal. Time spent on MVPA was calculated using accelerometer data and age-specific cut points. In fasting blood samples, we measured plasma glucose and c-peptide and used the Homeostasis Model Assessment 2-Insulin Resistance (HOMA2-IR) to estimate Insulin resistance. Results are adjusted for age, sex, BP, body mass index (BMI), HOMA2-IR, medication, and smoking. We included 824 adults (mean age = 61.6 years) with recently diagnosed T2DM (interquartile range for diabetes duration = 4.9 years). 41% were females. Median MVPA was 10.7 min/day, and 50.5% had high SVR. Increments of 14.4 min/day in MVPA were independently associated with a lower risk of high SVR (OR = 0.69, [0.57;0.83]). Other risk determinants of high SVR were female sex (OR = 2.06, [1.49;2.86]), each increase in BMI of 6.16 kg/m2 (OR = 2.20, [1.76;2.73]), and HOMA2-IR of 1.79 (OR = 2.33, [1.09;4.96]). BMI had a notably greater impact on explained variability of SVR than MVPA when comparing the coefficient of determination (pseudo-R2, 35.0% vs. 7.9%). Although increased levels of MVPA are associated with a reduced risk of high SVR, BMI appears to have a more pronounced effect on SVR.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2: Forest plot of adjusted odds ratios from overall and subgroup analyses on the association between standardized MVPA (Moderate to Vigorous Physical Activity) and SVR (Systemic Vascular Resistance): adjusted odds ratios were obtained from binary logistic regression assessing the association between standardized MVPA-time and dichotomized SVR as normal or high SVR.
Fig. 3: Incremental impact of selected standardized variables on pseudo R-squared when added last to the model: pseudo R2 values were obtained using binary logistic regression of the association between the selected clinical predictors and dichotomized SVR as normal or high SVR.

Similar content being viewed by others

Data availability

The datasets generated during and/or analysed during the current study are not publicly available due to Danish data security regulations but are available from the corresponding author on reasonable request.

References

  1. Rossier BC, Bochud M, Devuyst O. The hypertension pandemic: an evolutionary perspective. Physiology. 2017;32:112–25.

    Article  PubMed  CAS  Google Scholar 

  2. Julius S. Phenotypic changes in the transition from prehypertension to established hypertension. In: Berbari AE, Mancia G, editors. Disorders of blood pressure regulation: phenotypes, mechanisms, therapeutic options. Cham: Springer International Publishing; 2018. pp. 587–98.

  3. Lu DY, Fang Q, Bibby D, Arora B, Schiller NB. Association of systemic vascular resistance analog and cardiovascular outcomes: The Heart and Soul Study. J Am Heart Assoc. 2022;11:e026016.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018;34:575–84.

    PubMed  Google Scholar 

  5. Lastra G, Syed S, Kurukulasuriya LR, Manrique C, Sowers JR. Type 2 diabetes mellitus and hypertension. Endocrinol Metab Clin North Am. 2014;43:103–22.

    Article  PubMed  Google Scholar 

  6. Rijal A, Nielsen EE, Adhikari TB, Dhakal S, Maagaard M, Piri R, et al. Effects of adding exercise to usual care in patients with either hypertension, type 2 diabetes or cardiovascular disease: a systematic review with meta-analysis and trial sequential analysis. Br J Sports Med. 2023;57:930–9.

    Article  PubMed  Google Scholar 

  7. Carey RM, Moran AE, Whelton PK. Treatment of hypertension. JAMA. 2022;328:1849.

    Article  PubMed  CAS  Google Scholar 

  8. Fagard RH. Exercise is good for your blood pressure: effects of endurance training and resistance training. Clin Exp Pharmacol Physiol. 2006;33:853–6.

    Article  PubMed  CAS  Google Scholar 

  9. McDonnell, Maki-Petaja BJ, Munnery KM, Yasmin M, Wilkinson IB, Cockcroft JR, et al. Habitual exercise and blood pressure: age dependency and underlying mechanisms. Am J Hypertens. 2013;26:334–41.

    Article  PubMed  Google Scholar 

  10. Ring M, Eriksson MJ, Fritz T, Nyberg G, Östenson CG, Krook A, et al. Influence of physical activity and gender on arterial function in type 2 diabetes, normal and impaired glucose tolerance. Diab Vasc Dis Res. 2015;12:315–24.

    Article  PubMed  Google Scholar 

  11. Loimaala A, Huikuri HV, Kööbi T, Rinne M, Nenonen A, Vuori I. Exercise training improves baroreflex sensitivity in type 2 diabetes. Diabetes. 2003;52:1837–42.

    Article  PubMed  CAS  Google Scholar 

  12. Sacre JW, Holland DJ, Jenkins C, Sharman JE. Augmentation index immediately after maximal exercise in patients with type 2 diabetes mellitus. Med Sci Sports Exerc. 2012;44:75–83.

    Article  PubMed  CAS  Google Scholar 

  13. Stidsen JV, Nielsen JS, Henriksen JE, Friborg SG, Thomsen RW, Olesen TB, et al. Protocol for the specialist supervised individualised multifactorial treatment of new clinically diagnosed type 2 diabetes in general practice (IDA): a prospective controlled multicentre open-label intervention study. BMJ Open. 2017;7:e017493.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Nielsen JS, Thomsen RW, Steffensen C, Christiansen JS. The Danish centre for strategic research in type 2 Diabetes (DD2) study: implementation of a nationwide patient enrollment system. Clin Epidemiol. 2012;4:27–36.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Faini A, Omboni S, Tifrea M, Bubenek S, Lazar O, Parati G. Cardiac index assessment: validation of a new non-invasive very low current thoracic bioimpedance device by thermodilution. Blood Press. 2014;23:102–8.

    Article  PubMed  Google Scholar 

  16. Talvik A, Rebora P, Heinpalu-Kuum M, Salerno S, Miszkowska-Nagórna E, Liu X, et al. Non-invasive hemodynamic monitoring as a guide to drug treatment of uncontrolled hypertensive patients: effects on home blood pressure in the BEAUTY study. Blood Press. 2018;27:368–75.

    Article  PubMed  Google Scholar 

  17. Brønd JC, Aadland E, Andersen LB, Resaland GK, Andersen SA, Arvidsson D. The ActiGraph counts processing and the assessment of vigorous activity. Clin Physiol Funct Imaging. 2019;39:276–83.

    Article  PubMed  Google Scholar 

  18. Domazet SL, Tarp J, Thomsen RW, Højlund K, Stidsen JV, Brønd JC, et al. Accelerometer-derived physical activity and sedentary behaviors in individuals with newly diagnosed type 2 diabetes: a cross-sectional study from the Danish nationwide DD2 cohort. Front Sports Act Living. 2022;4:1089579.

    Article  PubMed  Google Scholar 

  19. Ahrensberg H, Toftager M, Nørgaard S, Petersen CB. Fysisk aktivitet for voksne (18-64 år): Viden om sundhed og forebyggelse. Sundhedsstyrelsen, 2023. 79 p.

  20. DeMers D, Wachs D. Physiology, Mean Arterial Pressure. [Updated 2023 Apr 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538226/.

  21. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Hill NR, Levy JC, Matthews DR. Expansion of the homeostasis model assessment of β-cell function and insulin resistance to enable clinical trial outcome modeling through the interactive adjustment of physiology and treatment effects: iHOMA2. Diabetes Care. 2013;36:2324–30.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Kähönen E, Aatola H, Lehtimäki T, Haarala A, Sipilä K, Juonala M, et al. Influence of early life risk factors and lifestyle on systemic vascular resistance in later adulthood: the cardiovascular risk in young Finns study. Blood Press. 2021;30:367–75.

    Article  PubMed  Google Scholar 

  24. Green DJ, Smith KJ. Effects of exercise on vascular function, structure, and health in humans. Cold Spring Harb Perspect Med. 2018;8:a029819.

    Article  PubMed  PubMed Central  Google Scholar 

  25. MacIntosh BR, Murias JM, Keir DA, Weir JM. What is moderate to vigorous exercise intensity? Front Physiol. 2021;12:682233.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Bogaert YE, Linas S. The role of obesity in the pathogenesis of hypertension. Nat Clin Pract Nephrol. 2009;5:101–11.

    Article  PubMed  CAS  Google Scholar 

  27. Ahmed B, Sultana R, Greene MW. Adipose tissue and insulin resistance in obese. Biomed Pharmacother. 2021;137:111315.

    Article  PubMed  CAS  Google Scholar 

  28. Di Pino A, DeFronzo RA. Insulin resistance and atherosclerosis: implications for insulin-sensitizing agents. Endocr Rev. 2019;40:1447–67.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Thorp AA, Schlaich MP. Relevance of sympathetic nervous system activation in obesity and metabolic syndrome. J Diabetes Res. 2015;2015:341583.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Chen J, Wang X, Dong B, Liu C, Zhao J, Dong Y, et al. Cardiac function and exercise capacity in patients with metabolic syndrome: a cross-sectional study. Front Cardiovasc Med. 2022;9:974802.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Coutinho T, Borlaug BA, Pellikka PA, Turner ST, Kullo IJ. Sex differences in arterial stiffness and ventricular-arterial interactions. J Am Coll Cardiol. 2013;61:96–103.

    Article  PubMed  Google Scholar 

  32. Krzesiński P, Stańczyk A, Gielerak G, Uziębło-Życzkowska B, Kurpaska M, Piotrowicz K, et al. Sex determines cardiovascular hemodynamics in hypertension. J Hum Hypertens. 2015;29:610–7.

    Article  PubMed  Google Scholar 

  33. Raj A, Chakole S, Agrawal S, Gupta A, Khekade H, Prasad R, et al. The impact of menopause on cardiovascular aging: a comprehensive review of androgen influences. Cureus. 2023;15:e43569.

    PubMed  PubMed Central  Google Scholar 

  34. Joyner MJ, Wallin BG, Charkoudian N. Sex differences and blood pressure regulation in humans. Exp Physiol. 2016;101:349–55.

    Article  PubMed  Google Scholar 

  35. Arvidsson D, Fridolfsson J, Börjesson M. Measurement of physical activity in clinical practice using accelerometers. J Intern Med. 2019;286:137–53.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We would like to extend our sincere gratitude to the many patients who participated in the IDA study. Their contributions have made this research project possible.

Funding

The study was supported by the Danish Agency for Science (grant nos. 09-067009 and 09-075724), the Region of Southern Denmark, the Region of Zealand, the Augustinus Foundation, the Herta Christensen Foundation, the Novo Nordisk Foundation and the University of Southern Denmark. The Biobank was supported by an unrestricted donation from Novo Nordisk A/S. Project partners are listed on the project website (https://dd2.dk/).

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization of IDA study: JVS, TBO, JSN and Henning Beck-Nielsen Conceptualization of current study: SBN, TBO and JVS. Data curation: JVS. Formal analysis: SBN, TBO and JVS. Investigation: TBO and JVS. Methodology: SBN, TBO, JVS, SLD, SFK, JSN and MHO. Supervision: TBO and JVS. Validation: TBO, JVS, SLD, SFK, JSN and MHO. Writing – original draft preparation: SBN, TBO and JVS. Writing – review & editing: TBO, JVS, SLD, SFK, JSN and MHO. All authors provided critical comment.

Corresponding author

Correspondence to Son Bao Nguyen.

Ethics declarations

Competing interests

MHO has in relation to lectures received honorary from Novo Nordisk A/S, Teva A/S, and AstraZeneca A/S.

Ethical approval

The IDA study was approved by the Regional Committee on Medical Health Ethics (Region of Southern Denmark S-20120186), the Danish Data Protection Agency and Medicines Authority (journal no. 2012120204) and was conducted in concordance with the Helsinki declaration II.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nguyen, S.B., Olesen, T.B., Domazet, S.L. et al. Impact of moderate to vigorous physical activity on systemic vascular resistance in Danish adults with recently diagnosed type 2 diabetes: a cross-sectional study. J Hum Hypertens 39, 701–708 (2025). https://doi.org/10.1038/s41371-025-01049-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41371-025-01049-x

Search

Quick links